Through our vast network, we help our corporate clients with their product strategy, presentation & communication of the data, and in- and out-licensing strategy, including asset valuation (NPV, rNPV) and commercial assessment.
We provide input on regulatory matters as well as support in pricing and reimbursement decisions and communication with decision-making authorities
We advise on the commercialization of research outputs from basic science to market, including advisory in spin-off processes.